The End of Ozempic: The Major Drawbacks Making Everyone Quit
Thomas DeLauer — The End of Ozempic: The Major Drawbacks Making Everyone Quit
Channel: Thomas DeLauer · Our label: Nutrition & fasting creator · Source: youtube.com/watch?v=Fjq4CY565po
What this video covers
With all the stuff that’s been popping up lately, maybe it’s the end of Ozimpic. Maybe we need to look at the actual drawbacks. But rather than just pointing fingers at the drawbacks, I want to understand these drawbacks. Really understand like what people are looking at, why this is coming out into the open so much, but more importantly, how we can potentially overcome it.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- You don’t overcome it by necessarily having so much of a solid plan while you’re on the compound.
- So, you might as well eat more protein and maybe some healthy fats because if you start overeating the carbohydrates, that’s going to be a metabolic problem, right?
- So, that’s a quick kind of fix to that to be able to establish a new lifestyle as you come off of it because it’s going to be very hard to get a new lifestyle change when you are actually on the compound itself.
- A lot of times when people are on a GLP-1 receptor agonist, they prefer to eat carbs.
- Well, because simply by the very gustatory sort of digestive nature and how GLP-1 works, it’s going to make it so you have a stronger aversion to fats.
- This next one I have to address a study that was published in the journal indocrine society that was a 68-week study on using using Osimpic.
Read next
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.